Cabaletta Bio, Inc. (CABA) Financials

CABA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 148.1 million 44.8 million
Dec. 31, 2025 165.1 million 53.0 million
Sept. 30, 2025 189.8 million 50.3 million
June 30, 2025 224.5 million 46.0 million

CABA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -42.6 million 5.3 million
Dec. 31, 2025 -35.5 million 4.3 million
Sept. 30, 2025 -34.6 million 5.8 million
June 30, 2025 -30.6 million 5.7 million

CABA Net Income

No data available :(

CABA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 116.6 million - 3.3 million
Dec. 31, 2025 133.6 million 2.9 million 27.1 million
Sept. 30, 2025 159.9 million 4.6 million 25.8 million
June 30, 2025 194.7 million - 24.9 million

CABA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 112.0 million
Dec. 31, 2025 102.3 million
Sept. 30, 2025 102.3 million
June 30, 2025 61.9 million

CABA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 37.4 million 6.9 million -
Dec. 31, 2025 205000 36.2 million 6.4 million -
Sept. 30, 2025 78000 39.8 million 6.8 million -
June 30, 2025 161000 37.6 million 8.3 million -

CABA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 337000
Dec. 31, 2025 - -1.3 million
Sept. 30, 2025 - 345000
June 30, 2025 - 468000

CABA

Price: $3.25

52 week price:
1.11
4.23

Earnings Per Share: -1.78 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 489500

Market Capitalization: 635.1 million

Links: